MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,913 Approvals
Showing 1401 to 1420 of 1,913 approvalsPage 71 of 96

Daxas

Authorisation: Jul 5, 2010

Votrient

Authorisation: Jun 14, 2010

Olanzapine Apotex

Authorisation: Jun 10, 2010
apotex europe bv

Topotecan Hospira

Authorisation: Jun 9, 2010

Nivestim

Authorisation: Jun 7, 2010

Tolura

Authorisation: Jun 4, 2010

Tolura

Authorisation: Jun 4, 2010

Prolia

Authorisation: May 26, 2010

Raloxifene Teva

Authorisation: Apr 29, 2010

Menveo

Authorisation: Mar 15, 2010

Temozolomide Accord

Authorisation: Mar 15, 2010

Ristaben

Authorisation: Mar 15, 2010

Tepadina

Authorisation: Mar 15, 2010

Ristfor

Authorisation: Mar 15, 2010

Revolade

Authorisation: Mar 11, 2010

Revolade

Authorisation: Mar 11, 2010

Urorec

Authorisation: Jan 29, 2010

Silodyx

Authorisation: Jan 29, 2010

Temozolomide Teva

Authorisation: Jan 28, 2010

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.